cefbuperazone has been researched along with aztreonam in 1 studies
| Studies (cefbuperazone) | Trials (cefbuperazone) | Recent Studies (post-2010) (cefbuperazone) | Studies (aztreonam) | Trials (aztreonam) | Recent Studies (post-2010) (aztreonam) |
|---|---|---|---|---|---|
| 92 | 5 | 1 | 213 | 0 | 32 |
| Protein | Taxonomy | cefbuperazone (IC50) | aztreonam (IC50) |
|---|---|---|---|
| Beta-lactamase | Escherichia coli | 0.032 | |
| Penicillin-binding protein 1A | Pseudomonas aeruginosa PAO1 | 3.34 | |
| Efflux transporter | Salmonella enterica subsp. enterica serovar Newport | 0.006 | |
| Beta-lactamase | Klebsiella pneumoniae | 0.006 | |
| AmpC | Escherichia coli | 0.06 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
1 other study(ies) available for cefbuperazone and aztreonam
| Article | Year |
|---|---|
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |